- Patent Title: Anti-integrin β1 antibody compositions and methods of use thereof
-
Application No.: US14140340Application Date: 2013-12-24
-
Publication No.: US10023638B2Publication Date: 2018-07-17
- Inventor: W. Shawn Carbonell
- Applicant: ONCOSYNERGY, INC.
- Applicant Address: US CA San Francisco
- Assignee: Oncosynergy, Inc.
- Current Assignee: Oncosynergy, Inc.
- Current Assignee Address: US CA San Francisco
- Agency: DLA Piper LLP (US)
- Main IPC: C07K16/00
- IPC: C07K16/00 ; C07K16/46 ; C07K16/28 ; A61K49/00 ; G01N33/574 ; A61K47/68 ; A61K39/00
Abstract:
The current invention provides human variable chain framework regions and humanized antibodies comprising the framework regions, the antibodies being specific for integrin β1. The invention also provides methods for utilizing the antibodies, for example to treat diseases such as cancer.
Public/Granted literature
- US20140328830A1 ANTI-INTEGRIN BETA-1 ANTIBODY COMPOSITIONS AND METHODS OF USE THEREOF Public/Granted day:2014-11-06
Information query
